Rheumatoid arthritis

Quantitative magnetic resonance imaging (MRI) tenosynovitis volume explains the association between tendon involvement and future development of clinical arthritis in anti-cyclic citrullinated peptide-positive at-risk individuals

Ann Rheum DisPublished Prospective cohort study

Authors' conclusion

MRI-derived TSV independently predicts IA and outperforms SV.

Study context

Population
Anti-CCP-positive individuals with musculoskeletal symptoms without clinical synovitis, baseline contrast-enhanced MRI of hand and wrist
Participants
223 individuals
Exposure
Progressors vs non-progressors to inflammatory arthritis; MRI tenosynovitis volume vs synovitis volume as predictors
  • Progressorsn = 67
Outcome
Progression to IA (≥1 clinically swollen joint)
Follow-up
median 13.3-month follow-up
Methodological detailsquantitative MRI volumetric assessment, Cox regression, ROC analysis
  • Quantitative MRI volumetric assessment
  • Cox regression
  • ROC analysis

Main finding

As reported in the abstract

Baseline TSV

P = 0.003

Developed inflammatory arthritis (IA)
67 (30%)
Tenosynovitis (TSV) remained predictive after adjusting for synovitis (SV)
P = 0.008
AUC for IA, TSV vs SV
0.697 vs 0.582
TSV independently predicted progression in multivariable analysis
P < 0.001
Tender joint count independently predicted progression
P = 0.014

Observational data: associations, not effects.

Further findings

Baseline tenosynovitis (34.5%) associated with progression

Association with progression
P < 0.001

Total inflammation volume and time to progression

Higher volume correlated with shorter time to progression
P = 0.008

Inter-reader agreement for volumetric scoring

Intraclass correlation coefficient, all regions
> 0.90

Original publication

Quantitative MRI tenosynovitis volume explains the association between tendon involvement and future development of clinical arthritis in anti-cyclic citrullinated peptide-positive at-risk individuals. Ann Rheum Dis. Published 10 March 2026. doi:10.1016/j.ard.2025.10.020

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.